Type 2 diabetes is often associated with excessive sugar intake, but lifestyle factors including body weight, exercise, and smoking habits can also influence risk. A new study published in Diabetology has found that greater ...
May 27, 2026
0
123
A team of scientists from the University of Granada (UGR), the Granada Institute for Biomedical Research (ibs.GRANADA), the Public University of Navarra and the Biomedical Research Networking Center (CIBER) has demonstrated ...
Jul 3, 2026
0
115
For a very long time, bariatric surgery, in which doctors removed a portion of the stomach, was the standard procedure for helping patients lose weight and manage obesity, alongside metabolic disorders such as diabetes, high ...
A pioneering food additive that can stop people from gaining weight has appeared on the EU's Novel Food List, indicating its safety for human consumers. Inulin propionate ester, or IPE, is a dietary fiber developed and tested ...
Jul 2, 2026
0
107
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...
Jun 24, 2026
1
83
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs ...
May 4, 2026
0
77
For generations, early to bed and early to rise was seen as the blueprint for a healthy life, and any departure from it was often considered unhealthy. Scientists, however, have discovered that whether someone is an early ...
Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published ...
Mar 10, 2026
0
76
Body Mass Index (BMI) has long been used in public health and clinical settings as a simple tool to classify an individual's physical status based on their height and weight. Originally developed in the 1830s by Belgian mathematician ...
A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing to keep off 25% of the ...
Mar 4, 2026
0
75
